TCH-165

TCH-165 is a modulator of Proteasome used in studies of Protein Degradation / Proteasome. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to ubiquitin-dependent turnover, proteostasis, and targeted protein degradation in cancer, immunology, and inflammation models.

By modulating Proteasome, TCH-165 can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In cancer, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Proteasome
• Pathway perturbation studies connected to Protein Degradation / Proteasome
• Context-dependent response profiling and mechanism comparison
• Protease-activity, cleavage, and substrate-processing assays

Overall, TCH-165 is appropriate when a defined chemical perturbant is needed to connect Proteasome with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.